Dan Zimmerman, Ken S. Rosenthal, and Eyal Talor | Apr 1, 2007 | 8 min read
The Vaccine Conundrum A highly effective strategy is all but ignored by many companies and investors. Why, and what can be done to boost funding?By Dan Zimmerman, Ken S. Rosenthal, and Eyal Talor ARTICLE EXTRASDavid Bloom on why vaccines are a good investment They've eradicated smallpox, and all but eradicated polio. Their successes in lowering the disease burden of any number of other diseases are wel